Effect of propranolol with melatonin on the clinical symptoms in children with migraine

Phase 2

• Conditions: Migraine without sleep disorder.; Migraine without aura; G43.0

• Registration Number: IRCT20120215009014N345
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Age of 5 to 15 years
Migraine without sleep disorder

Exclusion Criteria

Contraindication of propranolol or melatonin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of headache. Timepoint: Before the intervention and 1 and 3 months after that. Method of measurement: By using Visual Analog Scale (VAS).;Nausea and vomiting. Timepoint: Before the intervention and 1 and 3 months after that. Method of measurement: By taking history.;Photophobia. Timepoint: Before the intervention and 1 and 3 months after that. Method of measurement: By taking history.;Phonophobia. Timepoint: Before the intervention and 1 and 3 months after that. Method of measurement: By taking history.